JPS Oncology & Infusion Center

Fort Worth, Texas 76104

1 studies enrolling now · 2 studies all time

What they study most

Epidermal Growth Factor Receptor Gene Mutation, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Non Small Cell Lung Cancer, Stage III Lung Cancer, Stage IV Lung Cancer

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients — Recruiting now